1. Home
  2. OSPN vs MRVI Comparison

OSPN vs MRVI Comparison

Compare OSPN & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpan Inc.

OSPN

OneSpan Inc.

HOLD

Current Price

$12.85

Market Cap

495.5M

Sector

Technology

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$4.00

Market Cap

449.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSPN
MRVI
Founded
1991
2014
Country
United States
United States
Employees
341
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
495.5M
449.6M
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
OSPN
MRVI
Price
$12.85
$4.00
Analyst Decision
Strong Buy
Buy
Analyst Count
3
7
Target Price
$17.00
$4.57
AVG Volume (30 Days)
537.8K
1.2M
Earning Date
02-26-2026
02-24-2026
Dividend Yield
3.68%
N/A
EPS Growth
99.92
N/A
EPS
1.49
N/A
Revenue
$241,436,000.00
$192,435,000.00
Revenue This Year
$0.69
N/A
Revenue Next Year
$1.96
$9.04
P/E Ratio
$8.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.00
$1.67
52 Week High
$20.37
$6.05

Technical Indicators

Market Signals
Indicator
OSPN
MRVI
Relative Strength Index (RSI) 50.79 66.60
Support Level $12.82 $3.79
Resistance Level $13.20 $4.02
Average True Range (ATR) 0.33 0.18
MACD 0.03 0.06
Stochastic Oscillator 66.35 87.43

Price Performance

Historical Comparison
OSPN
MRVI

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: